Moleculin Biotech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MBRX and other ETFs, options, and stocks.

About MBRX

Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses. 

CEO
Walter V. Klemp
CEOWalter V. Klemp
Employees
17
Employees17
Headquarters
Houston, Texas
HeadquartersHouston, Texas
Founded
2015
Founded2015
Employees
17
Employees17

MBRX Key Statistics

Market cap
9.01M
Market cap9.01M
Price-Earnings ratio
-0.12
Price-Earnings ratio-0.12
Dividend yield
—
Dividend yield—
Average volume
1.66M
Average volume1.66M
High today
$0.667
High today$0.667
Low today
$0.63
Low today$0.63
Open price
$0.6537
Open price$0.6537
Volume
305.40K
Volume305.40K
52 Week high
$4.90
52 Week high$4.90
52 Week low
$0.3975
52 Week low$0.3975

People also own

Based on the portfolios of people who own MBRX. This list is generated using Robinhood data, and it’s not a recommendation.
SNDL
Tilray Brands
Plug Power
NIO
Bionano Genomics
Workhorse
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.